LEADER 01990nam a2200385 u 4500
001 EB002000263
003 EBX01000000000000001163164
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
020 |a 1587631202 
020 |a 9781587631207 
100 1 |a Bader, James D. 
245 0 0 |a Cardiovascular effects of epinephrine on hypertensive dental patients  |h Elektronische Ressource  |c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Research Triangle Institute ; James D. Bader, principal investigator ; Arthur J. Bonito, Daniel A. Shugars, investigators 
260 |a Rockville, MD  |b U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality  |c [2002], 2002 
300 |a vii, 67 p.  |b ill.  |c 28 cm 
505 0 |a Includes bibliographical references 
653 |a Outcome Assessment, Health Care / https://id.nlm.nih.gov/mesh/D017063 
653 |a Heart Rate / drug effects / https://id.nlm.nih.gov/mesh/D006339Q000187 
653 |a Epinephrine / adverse effects / https://id.nlm.nih.gov/mesh/D004837Q000009 
653 |a Blood Pressure / drug effects / https://id.nlm.nih.gov/mesh/D001794Q000187 
653 |a Vasoconstrictor Agents / adverse effects / https://id.nlm.nih.gov/mesh/D014662Q000009 
653 |a Dental Care / https://id.nlm.nih.gov/mesh/D003729 
653 |a Hypertension / https://id.nlm.nih.gov/mesh/D006973 
700 1 |a Bonito, Arthur J. 
700 1 |a Shugars, Daniel A. 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
710 2 |a Research Triangle Institute 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence report/technology assessment 
500 |a "July 2002." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK33889  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 700 
082 0 |a 610